Cargando…
Salivary Antibody Responses to Two COVID-19 Vaccines following Different Vaccination Regimens
Background: To date, little is known about the salivary mucosal immune response following different COVID-19 vaccine types or after a booster (3rd) dose of the BNT162b2 (BNT) vaccine. Methods: A total of 301 saliva samples were collected from vaccinated individuals and arranged into two cohorts: coh...
Autores principales: | Alkharaan, Hassan, Al-Qarni, Hatem, Aldosari, Muath A., Alsaloum, Mohammed, Aldakheel, Ghada, Alenazi, Mohammed W., Alharbi, Naif Khalaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146373/ https://www.ncbi.nlm.nih.gov/pubmed/37112657 http://dx.doi.org/10.3390/vaccines11040744 |
Ejemplares similares
-
Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022) -
Vaccination strategies for mitigation of MERS-CoV outbreaks
por: Bosaeed, Mohammad, et al.
Publicado: (2023) -
Herpetic Keratitis and Corneal Endothelitis Following COVID-19 Vaccination: A Case Series
por: Alkwikbi, Hassan, et al.
Publicado: (2022) -
Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022) -
Seroprevalence of COVID-19 in Riyadh city during the early increase of COVID-19 infections in Saudi Arabia, June 2020
por: Alenazi, Mohammed W., et al.
Publicado: (2022)